|
1
|
Noronha IL, Fujihara CK and Zatz R: The
inflammatory component in Progressive renal disease - are
interventions possible? Nephrol Dial Transplant. 17:363–368. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Filiopoulos V and Vlassopoulos D:
Inflammatory syndrome in chronic kidney disease: pathogenesis and
influence on outcomes. Inflamm Allergy Drug Targets. 8:369–382.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chevalier RL, Forbes MS and Thornhill BA:
Ureteral obstruction as a model of renal interstitial fibrosis and
obstructive nephropathy. Kidney Int. 75:1145–1152. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chevalier RL, Thornhill BA, Forbes MS and
Kiley SC: Mechanisms of renal injury and progression of renal
disease in congenital obstructive nephropathy. Pediatr Nephrol.
25:687–697. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Grande MT, Pérez-Barriocanal F and
López-Novoa JM: Role of inflammation in túbulo-interstitial damage
associated to obstructive nephropathy. J Inflamm (Lond).
7:192010.
|
|
6
|
Fries E and Blom AM: Bikunin - not just a
plasma proteinase inhibitor. Int J Biochem Cell Biol. 32:125–137.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fang Y, Xu P, Gu C, et al: Ulinastatin
improves pulmonary function in severe burn-induced acute lung
injury by attenuating inflammatory response. J Trauma.
71:1297–1304. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xu M, Wen XH, Chen SP, An XX and Xu HY:
Addition of ulinastatin to preservation solution promotes
protection against ischemia-reperfusion injury in rabbit lung. Chin
Med J (Engl). 124:2179–2183. 2011.PubMed/NCBI
|
|
9
|
Gao C, Huan J, Li W and Tang J: Protective
effects of Ulinastatin on pancreatic and renal damage in rats
following early scald injury. Burns. 35:547–552. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang Q, Liu X, Liu M, Zhang L and Guan Y:
Ulinastatin-mediated protection against zymosan-induced multiple
organ dysfunction in rats. Biologicals. 38:552–556. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Katoh H, Ishikawa H, Hasegawa M, et al:
Protective effect of urinary trypsin inhibitor on the development
of radiation-induced lung fibrosis in mice. J Radiat Res.
51:325–332. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lange-Sperandio B, Trautmann A, Eickelberg
O, et al: Leukocytes induce epithelial to mesenchymal transition
after unilateral ureteral obstruction in neonatal mice. Am J
Pathol. 171:861–871. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lu J, Chen YP, Wan R, Guo CY and Wang XP:
Protective effects of ulinastatin on acute liver failure induced by
lipopolysaccharide/D-galactosamine. Dig Dis Sci. 57:399–404. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shin IW, Jang IS, Lee SM, et al:
Myocardial protective effect by ulinastatin via an
anti-inflammatory response after regional ischemia/reperfusion
injury in an in vivo rat heart model. Korean J Anesthesiol.
61:499–505. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nam NH: Naturally occurring NF-kappaB
inhibitors. Mini Rev Med Chem. 6:945–951. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Baugé C, Beauchef G, Leclercq S, et al:
NFkappaB mediates IL-1beta-induced down-regulation of TbetaRII
through the modulation of Sp3 expression. J Cell Mol Med.
12:1754–1766. 2008.PubMed/NCBI
|
|
17
|
Gao C, Li R and Wang S: Ulinastatin
protects pulmonary tissues from lipopolysaccharide-induced injury
as an immunomodulator. J Trauma Acute Care Surg. 72:169–176.
2012.PubMed/NCBI
|
|
18
|
Wu YJ, Ling Q, Zhou XH, et al: Urinary
trypsin inhibitor attenuates hepatic ischemia-reperfusion injury by
reducing nuclear factor-kappa B activation. Hepatobiliary Pancreat
Dis Int. 8:53–58. 2009.
|
|
19
|
Ning XH, Ge XF, Cui Y and An HX:
Ulinastatin inhibits unilateral ureteral obstruction-induced renal
interstitial fibrosis in rats via transforming growth factor β
(TGF-β)/Smad signalling pathways. Int Immunopharmacol. 15:406–413.
2013.PubMed/NCBI
|
|
20
|
Ferenbach D, Kluth DC and Hughes J:
Inflammatory cells in renal injury and repair. Semin Nephrol.
27:250–259. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Spann KM, Tran KC and Collins PL: Effects
of nonstructural proteins NS1 and NS2 of human respiratory
syncytial virus on interferon regulatory factor 3, NF-kappaB, and
proinflammatory cytokines. J Virol. 7:5353–5362. 2005. View Article : Google Scholar
|
|
22
|
Esteban V, Lorenzo O, Rupérez M, et al:
Angiotensin II, via AT1 and AT2 receptors and NF-kappaB pathway,
regulates the inflammatory response in unilateral ureteral
obstruction. J Am Soc Nephrol. 15:1514–1529. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Miyajima A, Kosaka T, Seta K, et al: Novel
nuclear factor kappa B activation inhibitor prevents inflammatory
injury in unilateral ureteral obstruction. J Urol. 169:1559–1563.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yeh YC, Wei WC, Wang YK, et al:
Transforming growth factor-{beta}1 induces Smad3-dependent {beta}1
integrin gene expression in epithelial-to-mesenchymal transition
during chronic tubulointerstitial fibrosis. Am J Pathol.
177:1743–1754. 2010. View Article : Google Scholar
|
|
25
|
Shirakihara T, Horiguchi K, Miyazawa K, et
al: TGF-β regulates isoform switching of FGF receptors and
epithelial-mesenchymal transition. EMBO J. 30:783–795. 2011.
|
|
26
|
Phanish MK, Wahab NA, Colville-Nash P,
Hendry BM and Dockrell ME: The differential role of Smad2 and Smad3
in the regulation of pro-fibrotic TGFbetal responses in human
proximal-tubule epithelial cells. Biochem J. 393:601–607. 2006.
View Article : Google Scholar : PubMed/NCBI
|
